49.41
Hims Hers Health Inc stock is traded at $49.41, with a volume of 83.20M.
It is up +6.76% in the last 24 hours and down -7.40% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$46.28
Open:
$47
24h Volume:
83.20M
Relative Volume:
2.20
Market Cap:
$12.37B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
71.61
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
-23.06%
1M Performance:
-7.40%
6M Performance:
+86.03%
1Y Performance:
+146.80%
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HIMS
Hims Hers Health Inc
|
49.41 | 12.37B | 1.78B | 164.40M | 236.51M | 0.69 |
![]()
PG
Procter Gamble Co
|
159.86 | 381.79B | 83.93B | 15.50B | 15.03B | 6.30 |
![]()
UL
Unilever Plc Adr
|
60.92 | 154.84B | 65.10B | 6.16B | 0 | 2.4569 |
![]()
CL
Colgate Palmolive Co
|
88.71 | 74.51B | 19.95B | 2.90B | 3.47B | 3.54 |
![]()
KMB
Kimberly Clark Corp
|
127.89 | 44.14B | 19.75B | 2.47B | 2.39B | 7.34 |
![]()
KVUE
Kenvue Inc
|
20.88 | 41.32B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-04-25 | Reiterated | Needham | Buy |
Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
Jan-07-25 | Initiated | BTIG Research | Buy |
Dec-17-24 | Initiated | Morgan Stanley | Overweight |
Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
Aug-22-24 | Initiated | Needham | Buy |
Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
May-22-24 | Downgrade | Citigroup | Buy → Neutral |
Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
Apr-10-24 | Initiated | Canaccord Genuity | Buy |
Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Dec-07-23 | Initiated | Imperial Capital | In-line |
Jul-28-23 | Initiated | TD Cowen | Outperform |
Apr-11-23 | Initiated | Robert W. Baird | Neutral |
Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Sep-07-22 | Initiated | Truist | Hold |
Jul-15-22 | Initiated | SVB Leerink | Underperform |
Apr-14-22 | Initiated | Guggenheim | Buy |
Apr-01-22 | Resumed | Credit Suisse | Outperform |
Mar-10-22 | Initiated | Deutsche Bank | Hold |
Dec-02-21 | Initiated | Jefferies | Hold |
Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
Jul-06-21 | Initiated | BofA Securities | Neutral |
May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Apr-21-21 | Initiated | Truist | Hold |
Mar-09-21 | Initiated | Credit Suisse | Neutral |
Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
Feb-17-21 | Initiated | Citigroup | Neutral |
Feb-12-21 | Initiated | Piper Sandler | Neutral |
Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Goes Global, Named To Top Stocks List: Build Your Growth Stock Watchlist With These Just Updated Screens - Investor's Business Daily
Where Will Hims & Hers Stock Be In 10 Years? - Barchart.com
Hims & Hers Health Inc Stock: Navigating High Volatility and a Rich Valuation - Daily Chhattisgarh News
Bet on Winning DuPont Analysis & Pick 3 Top Stocks - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - Barchart.com
Hims & Hers Health Annual Stockholders Meeting Results - TipRanks
Hims & Hers (HIMS) Stock Pauses After Explosive 134% Rally This Year, Highlighting Immense Growth - Daily Chhattisgarh News
These 2 Growth Stocks Are No-Brainer Buys Right Now - Yahoo Finance
VF Corp, MGM Resorts, PENN Entertainment, Hims & Hers Health, and Camping World Shares Are Soaring, What You Need To Know - Yahoo Finance
2 Reasons To Double Down On Hims & Hers Ahead Of August (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Skyrockets Over 8%, Extending a Phenomenal 147% Annual Gain - Daily Chhattisgarh News
Where are the Opportunities in (HIMS) - news.stocktradersdaily.com
Hims & Hers: An Excellent Subscription Business - Seeking Alpha
The controversial rise of Franken-pills: Telehealth companies push to mix meds in a single pill - Sherwood News
Hims & Hers (HIMS) Stock Dips Amid Profit-Taking, But Yearly Gains Exceed a Massive 134% - Daily Chhattisgarh News
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health and Sociedad Quimica y Minera de Chile have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Where Will Hims & Hers Stock Be in 10 Years? - The Globe and Mail
Noteworthy Thursday Option Activity: PARR, VZ, HIMS - Nasdaq
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth - Yahoo Finance
Hims & Hers (HIMS) Share Price Shows Explosive Growth, Surging Over 150% in a Year - Daily Chhattisgarh News
June 2025's Select Stocks That Could Be Trading Below Estimated Value - simplywall.st
Hims & Hers Health’s (HIMS) Equal Weight Rating Reaffirmed at Morgan Stanley - Defense World
3 Reasons We Love Hims & Hers Health (HIMS) - Yahoo Finance
HIMS Experiences Mixed Growth in App Downloads and Web Traffic | - GuruFocus
Hims & Hers (HIMS) Stock Soars, Capping a Year of Explosive Growth - Daily Chhattisgarh News
Hims & Hers Stock Falls After Eli Lilly Rules Out Telehealth Tie-Up: Citi Calls It Aggressive Stance, Retail Turns Bearish - MSN
Hims & Hers: The ZAVA Acquisition Catapults Growth In Europe's Weight-Loss Market - Seeking Alpha
Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound - MSN
Needham Lifts PT on Hims & Hers Health (HIMS) Stock, Maintains Buy Rating - MSN
Hims & Hers Health (NYSE:HIMS) Shares Down 1.8% on Insider Selling - Defense World
Citi Keeps Hims & Hers (HIMS) Price Target, Maintains Sell Rating - MSN
HIMS Faces Uncertain Future with Potential Eli Lilly Partnership - GuruFocus
Is Hims & Hers Health a Smart Buy Right Now? - MSN
Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound - Bloomberg.com
Hims & Hers stock falls after Lilly rules out partnership - Investing.com Australia
Lilly (LLY) Pacts Bar Telehealth Firms From Selling Copycat Zepbound - Bloomberg.com
Hims & Hers says its weight-loss business can grow as US market changes - Reuters
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell? - AOL.com
Hims & Hers Health's Strategy in the Evolving Weight-Loss Drug MarketNews and Statistics - IndexBox
Hims & Hers (NYSE: HIMS) Live: Complete Earnings Coverage - AOL.com
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLOIs it Time to Sell? - 24/7 Wall St.
Hims & Hers (HIMS) Stock Stays Flat After Volatile Session, Highlighting Massive Yearly Gains - Daily Chhattisgarh News
Analysis: Hims & Hers says its weight-loss business can grow as US market changes - Yahoo Finance
Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge - Yahoo Finance
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Hims & Hers Health Unusual Options Activity - Nasdaq
Hims & Hers (HIMS) Stock Tumbles 10% in a Week, Pausing a Meteoric 160% Annual Rally - Daily Chhattisgarh News
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of “Hold” from Analysts - Defense World
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hims Hers Health Inc Stock (HIMS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Option Exercise |
2.43 |
125,335 |
304,564 |
285,550 |
Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Sale |
56.76 |
128,127 |
7,271,950 |
160,215 |
Dudum Andrew | Chief Executive Officer |
Jun 17 '25 |
Sale |
59.22 |
65,110 |
3,855,542 |
95,105 |
Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Sale |
56.51 |
47,534 |
2,686,300 |
237,660 |
Boughton Soleil | Chief Legal Officer |
Jun 16 '25 |
Sale |
56.80 |
5,451 |
309,617 |
165,881 |
Boughton Soleil | Chief Legal Officer |
Jun 17 '25 |
Sale |
59.75 |
2,572 |
153,677 |
163,309 |
Becklund Irene | PAO |
Jun 17 '25 |
Sale |
59.75 |
8,485 |
506,979 |
712 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):